Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging

Acta Radiologica

Volumn 40, Issue 1, 1999, Pages 45-51

  Kvistad, Kjell Arne ^a   Lundgren, S ^a   Fjosne H E ^a   Smenes, E ^a   Smethurst, H B ^a   Haraldseth, O ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast neoplasms, MR; Contrast enhancement, perfusion imaging

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADODIAMIDE; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST; BREAST TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PATHOLOGY; PRECANCER; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 0032604554     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859909174402     Document Type: Article

References (28)

1. ARONEN H. J., GAZIT I. E., LOUIS D. N. et al.: Cerebral blood volume maps of gliomas. Comparison with tumor grade and histologic findings. Radiology 191 (1994), 41.
2. BOETES C., BARENTSZ J. O., MUS R. D. et al.: MR characterization of suspicious breast lesions with a gadolinium-enhanced turbo-FLASH subtraction technique. Radiology 193 (1994), 777.
3. BONÉ B., ASPELIN P., BRONGE L., ISBERG B., PERBECK L. & VERESS B.: Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol. 37 (1996), 208.
4. BONÉ B., PENTEK Z., PERBECK L. & VERESS B.: Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol. 38 (1997), 489.
5. BUADU L. A., MURAKAMI J., MURAYAMA S. et al.: Breast lesions. Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angionesis. Radiology 200 (1996), 639.
6. FISCHER U. V., HEYDEN D. V., VOSSHENRICH R. et al.: Signal/ time relation of benign and malignant lesions in dynamic 2D-MR imaging of the breast. RÖFO 158 (1993), 287.
7. FLICKINGER F. W. ALLISON J. D., SHERRY R. M. et al.: Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn. Reson. Imaging 11 (1993), 617.
8. FOLKMAN J. & SHING Y.: Angiogenesis. J. Biol. Chem. 267 (1992), 10931.
9. FROUGE C., GUINEBRETIERE J. M., CONTESSO G. et al.: Correlation between contrast enhancement in dynamic magnetic resonance imaging of breast and tumor angiogenesis. Invest. Radiol. 29 (1994), 1043.
10. GILLES R., GARNIER C., MEINGAN R et al.: Fibroadenomas of the breast. Histopathological/dynamic contrast-enhanced MR correlation. Eur. Radiol. 5 (1995), 511.
11. GILLES R., MEUNIER M., LUCIDARME O. et al.: Clustered breast calcifications. Evaluation by dynamic contrast-enhanced subtraction MRI. J. Comput. Assist. Tomogr. 20 (1996), 9.
12. GREENSTEIN OREL S., SCHNALL M. D., LIVOLSI V. A. & TROUPIN R. H.: Suspicious breast lesions. MR imaging with radiologie-pathologie correlation. Radiology 190 (1994), 485.
13. GRIBBESTAD I. S., NILSEN G., FJØSNE H. et al.: Contrast-enhanced magnetic resonance imagine of the breast. Acta Oncol. 31 (1992), 833.
14. GRIEBEL J., MAYR N. A., DE VRIES A. et al.: Assessment of tumor microcirculation - a new role of dynamic contrast MR imaging. J. Magn. Reson. Imaging 7 (1997), 111.
15. HARMS S. E., FLAMIG D. P., HESLEY K. L. et al.: MR imaging of the breast with rotating delivery of excitation off resonance. Clinical experience with pathologic correlation. Radiology 187 (1993), 493.
16. HEYWANG S. H., WOLF A., PRUSS E. et al.: MR imaging of the breast with Gd-DTPA. Use and limitations. Radiology 171 (1989), 95.
17. HULKA C. A., SMITH B. L., SGROI D. C. et al.: Benign and malignant breast lesions. Differentiation with echo-planar MR imaging. Radiology 197 (1995), 33.
18. KAISER W. A.: MR imaging promises earlier breast cancer diagnosis. Diagn. Imaging Int. 8 (1992), 88.
19. KESSLER M.: Debate grows over breast imagings future. Diagn. Imaging Eur. 13 (1997), 49.
20. KUHL C. K., BIELING H., GIESEKE J. et al.: Breast neoplasms. T2* susceptibility-contrast, first pass perfusion MR imaging. Radiology 202 (1997), 87.
21. KUHL C. K., BIELING H. B., GIESEKE J. et al.: Healthy pre-menopausal breast parenchyma in dynamic contrast enhanced MR imaging of the breast. Normal contrast medium enhancement and cyclical-phase dependency. Radiology 203 (1997), 137.
22. MÜLLER-SCHIMPFLE M., STOLL P., STERN W. et al.: Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography. AJR. 168 (1997), 1323.
23. REMPP K. A., BRIX G., WENZ F. et al.: Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193 (1994), 637.
24. RINCK P. A.: Some future perspectives of contrast agent development. Clin. MRI 5 (1995), 129.
25. SORENSEN A. G., TIEVSKY A. L., OSTERGAARD L. et al.: Contrast agents in functional MR imaging. J. Magn. Reson. Imaging 7 (1997), 47.
26. STOMPER P. C., HERMAN S., KLIPPENSTEIN D. L. et al.: Suspect breast lesions. Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197 (1995), 387.
27. SU S., SHEN J., TIAN G. et al.: A reevaluation of T1-and T2*-weighted imaging methods for myocardial perfusion. (Abstract, p. 684.) Proc. Soc. Magn. Reson. 1995. Berkeley, CA 1996.
28. VAN DIJKE C. F., BRASCH R. C. ROBERTS T. P. L. et al.: Mammary carcinoma model - correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198 (1996), 813.